VarmX begins 800-patient Phase 3 trial of VMX-C001 for urgent surgery in Factor Xa inhibitor patients
The global EquilibriX-S trial will compare VMX-C001 with usual pharmacological care in approximately 800 patients taking Factor Xa inhibitors who require urgent high-bleeding-risk procedures.